Glaukos Corp GKOS:NYSE

RT Quote | NYSE | USD
Last | 06/29/22 EDT
45.75quote price arrow up+0.14 (+0.31%)
Volume
272,863
52 week range
33.33 - 86.35
Loading...
  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close45.75
  • 52 Week High86.35
  • 52 Week High Date07/01/21
  • 52 Week Low33.33
  • 52 Week Low Date05/10/22

Key Stats

  • Market Cap2.165B
  • Shares Out47.33M
  • 10 Day Average Volume0.43M
  • Dividend-
  • Dividend Yield-
  • Beta1.39
  • YTD % Change2.95

KEY STATS

  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close45.75
  • 52 Week High86.35
  • 52 Week High Date07/01/21
  • 52 Week Low33.33
  • 52 Week Low Date05/10/22
  • Market Cap2.165B
  • Shares Out47.33M
  • 10 Day Average Volume0.43M
  • Dividend-
  • Dividend Yield-
  • Beta1.39
  • YTD % Change2.95

RATIOS/PROFITABILITY

  • EPS (TTM)-0.61
  • P/E (TTM)-75.16
  • Fwd P/E (NTM)-25.94
  • EBITDA (TTM)-33.966M
  • ROE (TTM)-4.67%
  • Revenue (TTM)293.72M
  • Gross Margin (TTM)77.17%
  • Net Margin (TTM)-9.45%
  • Debt To Equity (MRQ)59.07%

EVENTS

  • Earnings Date08/03/2022(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Glaukos Corp

There is no recent news for this security.

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
Glaukos Corporation is an ophthalmic medical technology and pharmaceutical company. It is focused on developing novel therapies for the treatment of glaucoma, corneal disorders, and retinal disease. Its product candidates include Micro-Invasive Glaucoma Surgery (MIGS) products, which includes insertion of a micro-scale device or drug delivery system designed to reduce intraocular pressure (IOP) by restoring the natural aqueous humor outflow pathways for patients suffering...
Thomas Burns
Chairman of the Board, Chief Executive Officer
Joseph Gilliam
President, Chief Operating Officer
Alex Thurman
Chief Financial Officer, Senior Vice President
Address
229 Avenida Fabricante
San Clemente, CA
92672-7531
United States

Top Peers

SYMBOLLASTCHG%CHG
ATRC
AtriCure Inc
40.78+1.12+2.82%
INMD
Inmode Ltd
23.26+0.08+0.35%
NVRO
Nevro Corp
45.97-0.41-0.88%
AXNX
Axonics Inc
57.68+1.04+1.84%
CTKB
Cytek Biosciences Inc
10.87+0.13+1.21%